StockGlow

Newron Pharmaceuticals S.p.A. (NP5.DE)

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

12.60-0.03%Healthcare
Compare NP5.DE with
StockGlow Score
11
Bearish
BearishBullish
1 year ago+70.0%

The outlook

Newron Pharmaceuticals S.p.A. currently reads as bearish based on below its 50- & 200-day averages, 20% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range20% of the way from its 52-week low to high
Market cap
$262.2M
52-wk high
34.65
52-wk low
7.16
50-day avg
13.49
200-day avg
18.22
Trailing P/E
—

Similar stocks

NP5.FNewron Pharmaceuticals S.p.A.$12.60+4.13%NWRN.SWNewron Pharmaceuticals S.p.A.$11.88+0.68%88Q.DE4basebio PLC$5.55+0.00%C4G0.F51Talk Online Education Group$14.70+3.52%88Q.F4basebio PLC$5.50+0.92%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy